TECH logo

Bio-Techne (TECH)

Profile

Full Name

Bio-Techne Corporation

Ticker Symbol

TECH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 9, 1989

Indexes

S&P 500

Website

http://www.bio-techne.com

Employees

3100

Key Details

Price

$51.07(-2.80%)

Market cap

$8.07B(Mid cap)

Last Dividend

$0.08

TTM Dividend yield

0.63%

Annual revenue

$1.16B(+1.97% YoY)

Annual EPS

$1.05(-40.34% YoY)

PE ratio

51.59

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$51.07
TECH price is $51.07

30-Day Relative Volume

0.56
TECH 30-day relative volume is 0.56

Price Performance

Price Today change

-2.8%
TECH price is down -2.8% today

Price YTD change

-29.1%
TECH price is down -29.1% since January 1st

Price 1-year change

-22.05%
TECH price is down -22.05% year-on-year

Price 3-year change

-51.14%
TECH price is down -51.14% over the past 3 years

Price Range

Price All-time high

$135.96
TECH price is currently -62.44% below its historical high of $135.96

Price 3-year low

$46.44
TECH price is currently +9.97% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.07B
TECH market capitalization is $8.07 billion

Market cap 3-year change

-50.82%
TECH market capitalization is down -50.82% over the past 3 years

Market cap All-time high

$21.14B
TECH market capitalization is currently -61.82% below its historical high of $21.14 billion

Market cap sector rank

91.69%
TECH market capitalization is higher than 91.69% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.34%
TECH shares outstanding is up +0.34% year-on-year

Shares Outstanding 3-Year Change

+0.66%
TECH shares outstanding is up +0.66% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.10
TECH beta is 1.10

200-day SMA

$71.14
TECH price is currently -28.21% below its 200-day simple moving average

50-day SMA

$61.47
TECH price is currently -16.92% below its 50-day simple moving average

RSI

38.34
TECH 14-day relative strength index is 38.34

Volume

0.56
TECH 30-day relative volume is 0.56

ATR

$3.16
TECH average true range is $3.16

10-day Historical Volatility

96.64%
TECH 10-day historical volatility is 96.64%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.08
TECH last dividend was $0.08 per share, with an ex-dividend date of February 14, 2025

Next Dividend

-
TECH next dividend has not yet been announced

Dividend per share

Dividend per share

$0.32
TECH annual dividend per share is $0.32

Dividend per share Sector Rank

17.44%
TECH annual dividend per share is higher than 17.44% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
TECH {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
TECH {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend yield

0.63%
TECH annual dividend yield is 0.63%

Dividend yield Sector Rank

17.65%
TECH annual dividend yield is higher than 17.65% of companies in Healthcare sector

Other

Payout ratio

29.99%
TECH annual payout ratio is 29.99%

Dividends paid

$50.42M
TECH annual dividends paid is $50.42 million

Free cash flow

$236.10M
TECH annual free cash flow is $236.10 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.16B
TECH annual revenue is $1.16 billion

Revenue Analysts estimate

$1.23B
TECH annual revenue is currently -5.77% lower than the consensus analysts' forecast

Revenue 1-year change

+1.97%
TECH annual revenue is up +1.97% year-on-year

Revenue Sector rank

81.3%
TECH annual revenue is higher than 81.3% of companies in Healthcare sector

EPS

EPS

$1.05
TECH annual earnings per share is $1.05

EPS Analysts estimate

$1.89
TECH annual earnings per share is currently -44.47% lower than the consensus analysts' forecast

EPS 1-year change

-40.34%
TECH annual earnings per share is down -40.34% year-on-year

EPS Sector rank

89.66%
TECH annual earnings per share is higher than 89.66% of companies in Healthcare sector

Profit

Gross profit

$769.73M
TECH annual gross profit is $769.73 million

Gross margin

66.41%
TECH annual gross profit margin is 66.41%

Operating profit

$206.69M
TECH annual operating income is $206.69 million

Operating margin

17.83%
TECH annual operating profit margin is 17.83%

Net income

$168.10M
TECH annual net profit is $168.10 million

Net margin

14.50%
TECH annual net profit margin is 14.50%

Expenses

Total expenses

$952.37M
TECH annual total expenses is $952.37 million

Operating expenses

$563.04M
TECH annual total operating expenses is $563.04 million

Cost of goods sold

$389.33M
TECH annual cost of goods sold is $389.33 million

Selling, general & administrative expenses

$466.38M
TECH annual SGA is $466.38 million

Depreciation and amortization

$111.71M
TECH annual depreciation & amortization is $111.71 million

Interest expense

$15.74M
TECH annual interest expense is $15.74 million

Income tax

$17.58M
TECH annual income tax is $17.58 million

EBIT & EBITDA

EBIT

$206.69M
TECH annual earnings before interest & taxes is $206.69 million

EBITDA

$318.40M
TECH annual EBITDA is $318.40 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.70B
TECH annual total assets is $2.70 billion

Non current assets

$2.09B
TECH annual long term assets is $2.09 billion

Current assets

$617.42M
TECH annual total current assets is $617.42 million

Cash and cash equivalents

$151.79M
TECH annual cash & cash equivalents is $151.79 million

Accounts receivable

$241.39M
TECH annual accounts receivable is $241.39 million

Inventory

$179.73M
TECH annual inventory is $179.73 million

Liabilities

Total liabilities

$635.02M
TECH annual total liabilities is $635.02 million

Long term liabilities

$475.64M
TECH annual total long term liabilities is $475.64 million

Current liabilities

$159.38M
TECH annual total current liabilities is $159.38 million

Accounts payable

$37.97M
TECH annual accounts payable is $37.97 million

Debt

Total debt

$419.54M
TECH annual total debt is $419.54 million

Total debt 1-year change

-7.79%
TECH annual total debt is down -7.79% year-on-year

Long term debt

$406.62M
TECH annual long term debt is $406.62 million

Short term debt

$12.92M
TECH annual short term debt is $12.92 million

Equity & Capital

Shareholders equity

$2.07B
TECH annual stockholders equity is $2.07 billion

Book value

$2.07B
TECH annual book value is $2.07 billion

Retained earnings

$1.33B
TECH annual retained earnings is $1.33 billion

Working capital

$458.04M
TECH annual working capital is $458.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$298.98M
TECH annual cash flow from operations is $298.98 million

Cash from operations 1-year change

+17.53%
TECH annual cash flow from operations is up +17.53% year-on-year

Cash from investing

-$203.03M
TECH annual cash flow from investing activities is -$203.03 million

Cash from investing 1-year change

+23.57%
TECH annual cash flow from investing activities is up +23.57% year-on-year

Cash from financing

-$122.40M
TECH annual cash flow from financing activities is -$122.40 million

Cash from financing 1-year change

-641.2%
TECH annual cash flow from financing activities is down -641.2% year-on-year

CAPEX

CAPEX

$62.88M
TECH annual capital expenditures is $62.88 million

CAPEX 1-year change

+64.41%
TECH annual capital expenditures is up +64.41% year-on-year

Free Cash Flow

Free cash flow

$236.10M
TECH annual free cash flow is $236.10 million

Free cash flow 1-year change

+9.23%
TECH annual free cash flow is up +9.23% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

66.41%
TECH annual gross profit margin is 66.41%

Operating margin

17.83%
TECH annual operating profit margin is 17.83%

Net margin

14.50%
TECH annual net profit margin is 14.50%

ROA & ROE

ROA

6.29%
TECH annual return on assets is 6.29%

ROE

8.33%
TECH annual return on equity is 8.33%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

51.59
TECH price to earnings ratio is 51.59

PE ratio Sector rank

81.37%
TECH price to earnings ratio is higher than 81.37% of companies in Healthcare sector

PB Ratio

PB ratio

3.88
TECH price to book ratio is 3.88

PB ratio Sector rank

78.52%
TECH price to book ratio is higher than 78.52% of companies in Healthcare sector

PS Ratio

PS ratio

6.75
TECH price to sales ratio is 6.75

PS ratio Sector rank

73.08%
TECH price to sales ratio is higher than 73.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.29B
TECH enterprise value is $8.29 billion

Enterprise value Sector rank

90.99%
TECH enterprise value is higher than 90.99% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

26.78
TECH EV/EBITDA is 26.78

EV/EBITDA Sector rank

94%
TECH EV/EBITDA is higher than 94% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.87
TECH annual current ratio is 3.87

Quick ratio

2.75
TECH annual quick ratio is 2.75

Leverage

Debt to equity

0.15
TECH annual debt to equity ratio is 0.15

Interest coverage ratio

13.13
TECH annual interest coverage ratio is 13.13

Risk & Stability

Piotroski F-Score

7
TECH piotroski f-score is 7

Altman Z-Score

9.20
TECH altman z-score is 9.20

Analyst ratings

Recent major analysts updates

Apr 9, 25 Keybanc
Sector Weight
Apr 8, 25 Keybanc
Sector Weight
Mar 18, 25 Evercore ISI Group
Outperform
Mar 4, 25 Citigroup
Neutral
Feb 19, 25 Baird
Neutral
Feb 6, 25 Scotiabank
Sector Outperform
Feb 6, 25 RBC Capital
Sector Perform
Feb 6, 25 Keybanc
Overweight
Oct 31, 24 Scotiabank
Sector Outperform
Oct 31, 24 Baird
Outperform

Institutional Ownership

Similar stocks

EXAS logo
Exact Sciences (EXAS)
HSIC logo
Henry Schein (HSIC)
MASI logo
Masimo (MASI)
HALO logo
Halozyme Therapeutics (HALO)
CHE logo
Chemed (CHE)
ENSG logo
Ensign (ENSG)
TEM logo
Tempus AI (TEM)
CORT logo
Corcept Therapeutics Incorporated (CORT)
VTRS logo
Viatris (VTRS)
  • What is the ticker symbol for Bio-Techne?
  • Does Bio-Techne pay dividends?
  • What sector is Bio-Techne in?
  • What industry is Bio-Techne in?
  • What country is Bio-Techne based in?
  • When did Bio-Techne go public?
  • Is Bio-Techne in the S&P 500?
  • Is Bio-Techne in the NASDAQ 100?
  • Is Bio-Techne in the Dow Jones?
  • When was Bio-Techne's last earnings report?
  • When does Bio-Techne report earnings?
  • Should I buy Bio-Techne stock now?

What is the ticker symbol for Bio-Techne?

The ticker symbol for Bio-Techne is NASDAQ:TECH

Does Bio-Techne pay dividends?

Yes, Bio-Techne pays dividends. The last payment was $0.08, with an ex-dividend date on February 14, 2025

What sector is Bio-Techne in?

Bio-Techne is in the Healthcare sector

What industry is Bio-Techne in?

Bio-Techne is in the Biotechnology industry

What country is Bio-Techne based in?

Bio-Techne is headquartered in United States

When did Bio-Techne go public?

Bio-Techne's initial public offering (IPO) was on February 9, 1989

Is Bio-Techne in the S&P 500?

Yes, Bio-Techne is included in the S&P 500 index

Is Bio-Techne in the NASDAQ 100?

No, Bio-Techne is not included in the NASDAQ 100 index

Is Bio-Techne in the Dow Jones?

No, Bio-Techne is not included in the Dow Jones index

When was Bio-Techne's last earnings report?

Bio-Techne's most recent earnings report was on Feb 5, 2025

When does Bio-Techne report earnings?

The next expected earnings date for Bio-Techne is May 1, 2025

Should I buy Bio-Techne stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page